You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

PENICILLIN Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Penicillin, and what generic alternatives are available?

Penicillin is a drug marketed by Teva, Mylan, Purepac Pharm, Acs Dobfar Spa, Apothecon, Consolidated Pharm, Hq Speclt Pharma, Istituto Bio Ita Spa, Lilly, Parke Davis, Pfizer, Sandoz, Watson Labs Inc, Ivax Sub Teva Pharms, Wyeth Ayerst, Baxter Hlthcare, King Pharms Llc, Bristol Myers Squibb, Copanos, Pharmacia And Upjohn, Belcher Pharms, Chartwell Rx, Aurobindo Pharma, and Hikma Pharms. and is included in forty-six NDAs.

The generic ingredient in PENICILLIN is penicillin v potassium. There are ninety-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Penicillin

A generic version of PENICILLIN was approved as penicillin v potassium by CHARTWELL RX on November 23^rd, 1988.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PENICILLIN?
What are the global sales for PENICILLIN?
What is Average Wholesale Price for PENICILLIN?

Summary for PENICILLIN

US Patents:	0
Applicants:	24
NDAs:	46
Raw Ingredient (Bulk) Api Vendors:	28
Clinical Trials:	192
Drug Prices:	Drug price information for PENICILLIN
DailyMed Link:	PENICILLIN at DailyMed

Drug patent expirations by year for PENICILLIN

Drug Prices for PENICILLIN

Recent Clinical Trials for PENICILLIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Northern Ontario School of Medicine	N/A
China Medical University Hospital	N/A
Taoyuan General Hospital	N/A

See all PENICILLIN clinical trials

US Patents and Regulatory Information for PENICILLIN

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Belcher Pharms	PENICILLIN V POTASSIUM	penicillin v potassium	FOR SOLUTION;ORAL	061529-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva	PENICILLIN-VK	penicillin v potassium	TABLET;ORAL	060711-002	Approved Prior to Jan 1, 1982	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lilly	PENICILLIN G POTASSIUM	penicillin g potassium	TABLET;ORAL	060403-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sandoz	PENICILLIN G POTASSIUM	penicillin g potassium	INJECTABLE;INJECTION	065079-001	Aug 30, 2002		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.